Electrophysiological Aspects of the Action of Antiarrhythmic Drugs In this paper I shall first say a little about the chemical nature of ,3-receptor blocking compounds. I shall then describe some of their actions on cardiac muscle. Finally, on the level of pure speculation, I shall propose a possible explanation of their action in terms of current electrophysiological theory.
Twenty years have passed since Ahlquist (1948) made his suggestion that most of the effects of sympathomimetic and sympatholytic drugs could be explained by the existence of two kinds of receptor: a-receptors stimulated mainly by noradrenaline, and. mediating excitatory responses, such as vasoconstriction, contraction of nictitating membrane, &c.; and ,B-receptors, stimulated best by isoprenaline, and mediating relaxation of the bronchi and muscle vessels and, most important, the sympathetic stimulation of the force and rate of the heart-beat. At that time, the sympatholytic agents available blocked the hypothetical a-receptors, and it was not until ten years later that Ahlquist's proposal was triumphantly vindicated by the discovery by Powell & Slater (1958) that the dichloro analogue of isoprenaline blocked the supposed 13-receptors ( Fig 1) .
Dichloroisoprenaline, or DCI, was not of great practical value because it first stimulated p-receptors before it blocked them, but much greater specificity was achieved with the introduction four years later of pronethalol by ICI. This was withdrawn and replaced by propranolol. Subsequently several firms introduced other ,3-blockers, such as INPEA, MJ1999, Ciba 39 089 Ba oxprenolol (Trasicor), LB46, Simes C0405 (Butidrine) and IC150172. In several of them, the side chain is the same as it is in isoprenaline (e.g. pronethalol, MJ1999). The inclusion of an -O-CH2link between this chain and the ring increases 13-receptor blocking activity tenfold (propranolol, IC150172, LB46) . Changes in the ring greatly influence local anesthetic activity. It will be noted that there is an asymmetric carbon, the a carbon carrying a hydroxyl. The lkvo compounds have nmore than twenty times the activity of the dextro on ,-receptors. It thus seems probable that the compounds are attached at three sites. On the supposition that two of the fixation regions hold the ring and the P hydroxyl, then if the isopropylamino group points in the lkvo compound towards the third fixation region of the P-receptor, it will point away from it in the dextro compound (vide propranolol, Fig 1) . My colleagues and I had long been interested in the mode of action of antiarrhythmic drugs, and we had found that those available prior to the introduction of p-blockers had several features in common in the way they affected the cardiac action potential (Vaughan Williams 1958 , Szekeres & Vaughan Williams 1962 : (1) They did not alter the resting potential, even at high dosage.
(2) They did not increase the duration of repolarization, except to a trivial extent in relation to the considerable prolongation of the 'effective refractory period'. (3) They greatly reduced the rate of rise of the action potential. In short they mainly affected the depolarization process, not repolarization.
The sympathetic has long been implicated in the generation of arrhythmias. We found that pronethalol would not only block the classical arrhythmias in response to adrenaline plus chloroform, but also those induced by digitalis intoxication. Indeed the lethal dose of ouabain in guinea-pigs was increased by a prior protective injection of pronethalol (Vaughan Williams & Sekiya 1963) . To our surprise, however, it was found that pronethalol and propranolol had very similar actions to quinidine on the cardiac action potential (Vaughan Williams 1964) and were potent local anesthetics, about twice as active as procaine (Gill & Vaughan Williams 1964) .
Another curious fact is that sympathetic stimulation and adrenaline have effects on the cardiac action potential which seem to be the exact opposite of those produced by antiarrhythmic drugs. The rate of rise and 'overshoot' potential were increased (Hutter & Trautwein 1956) .
The problem then is to explain these actions in electrophysiological terms, and to facilitate discussion it may be advantageous to recall some of the evidence relating to the mechanism of operation of excitable tissues. It has been appreciated for more than a half-century that excitable tissues contained a great deal of potassium, and were negatively charged. This K concentration difference represented a 'potassium battery', the voltage of which was given by the equation
when the negative voltage inside the cell was just sufficient to prevent the high K concentration being dissipated, i.e. to maintain the K concentrations inside (Ki) and outside (Ko) the cell in equilibrium. For every observed concentration difference, there is an equilibrium voltage, defined at 37 C, and with conversion from 1lge to log,0, by E 60 mV log10 [Ki/Ko].
For example, if [Ki] 150mM, and [Ko] 5 mM, then [Ki/Ko] = 30, the log of which is 1-477. E 60 x 1477 89 mV approx. The energy for accumulating intracellular K is, of course, provided by the metabolism of the cell.
Until 1937 it was thought that an action potential represented a temporary short circuit of the K battery, but this hypothesis had to be abandoned when it was discovered that the action potential was larger than the resting potential by some 3OmV, so that the inside of the cell became positive to the outside at the active region (overshoot potential). Thus there were two batteries instead of one. Hodgkin and his colleagues produced a great deal of evidence that the second battery was a sodium battery, oppositely polarized, i.e. negative pole outside. The upstroke of the action potential was due to a net influx of sodium into the fibre, and in nerve was followed by a fast repolarization due to an accelerated net efflux of K ions (Hodgkin 1958). Since, from the evidence quoted above, the process of repolarization was little changed by antiarrhythmic drugs, our interest was concentrated upon the upstroke of the action potential. Two of the factors which influence the rate of rise of the action potential are: (1) The initial resting potential from which the activation 'takes off' (Weidmann 1955). (2) The sodium concentration difference. Our evidence was that neither of these was affected (Goodford & Vaughan Williams 1962) . Thus it appeared that there was some direct interference with the process of activation which permitted sodium to enter the fibre.
Hodgkin had shown that it was current ahead of the impulse, flowing from an inactive region into the active region, that was responsible for the membrane becoming active; this current depolarized the inactive region, and it was concluded that it was the depolarization itself which was responsible for increasing Na permeability; i.e. when the membrane voltage shifted from the resting potential in a positive direction, an 'Naswitch' was turned on.
This increase in sodium conductance (GNa), I had a maximum value GNa (G -!9T. Consequently the sodium conductance at any time could be expressed as a fraction, m, of this maximum, m having a value somewhere between 0 and I (GNa --GNa m). The fraction m was a function of both voltage and time. The simplest arrangement would have been if m had been directly proportional to depolarization, but it was evident that the relation was more complex, and fitted a cube function or higher power (GNa-GNa m3). A second observation was that as soon as the sodium switch was turned on, it began to turn itself off, so that there was only a brief explosive flash of sodium current, lasting a millisecond or less. This could be expressed by introducing another fraction, h, which also had a value between 0 and 1, but which was oppositely related to voltage. At the resting potential, about -7OmV, h was large, nearly 1 0, but although this particular sodium switch was on, almost no current flowed because m was small. On depolarization, m moved from near 0 towards 1. The rate constants determining the relation between the membrane voltage and m were faster than those diminishing h, so that momentarily both switches were on together, and a large sodium current flowed. On depolarization, however, h began to diminish, and turned the current off again (GNa GNa m3h). The depolarization process above is followed in nerve by repolarization occasioned by a rapid increase in K permeability (delayed rectification). In cardiac muscle repolarization takes place at least a hundred times more slowly, and the mechanism is highly controversial (Noble & Tsien 1968 ), but fortunately is not of immediate relevance because repolarization is little affected by antiarrhythmic compounds.
To recapitulate, the antiarryhythmic agents do not appear to have an effect on the potassium system. The voltage of the potassium battery, as reflected by the resting potential, is unchanged; nor do the potassium conductances, resting or active, seem to be altered. Likewise the voltage of the sodium battery is also unchanged. Indeed, it is probably the lack of action on metabolic functions which makes this group of compounds so safe. Thus it is the voltage-and-time-dependent sodium conductance which seems to be affected and, from what has been said, it is possible to suggest how this may be done. The membrane depolarizes, which increases Na-conductance rapidly. The influx of sodiium depolarizes the membrane more, so that by a positive feedback the sodium conductance rapidly rises to a maximum, and the factor m approaches 1. Meanwhile the factor h, which started at or near I, is affected more slowly by the depolarization, and it is not until after about a millisecond that its value falls towards 0, to cut off the sodium current. Thereafter the membrane remains absolutely refractory until repolarization has proceeded far enough for h to return once more to a larger value. The membrane remains stable, however, because the return of m to a small value is controlled by faster velocity constants than those governing h, so that m becomes small before h becomes large. It is suggested that antiarrhythmic agents, including quinidine and local anvsthetics, work by delaying still further the return of h to its resting value. Thus h might never return to a higher value than, say, 0-7, so that even long after full repolarization, the Na current could never reach more than 70 0 of its normal intensity, and the rate of rise of the action potential would be slowed. Secondly, one might speculate that excitation of ,3-receptors could remove some factor opposing the development of net inward current. If this were to occur before m had become small, an extrasystole would occur. This hypothesis would not only account for the arrhythmias induced by adrenaline and isoprenaline, but would also explain why P-receptor blocking agents are the most potent antiarrhythmics available. Not only would they have a 'non-specific' type of action of their own, delaying the return of h to a high value on repolarization, but they would also block the reversal of this situation by competing for f-receptor sites.
Dr Brian F Robinson (St Georges Hospital Medical School, London) Physiological and Clinical Effects of Inotropic Agents
An inotropic agent may be defined as something which has the capacity to increase the contractility of the myocardium. The main inotropic agents available for clinical or experimental use are cardiac glycosides, catecholamines (by stimulation of P-receptors), Ca++, and paired electrical stimu-Jation.
All inotropic agents have essentially the same effect upon the myocardium, although they may
